. 2019 Jan 1;10(1):17–29. doi: 10.18632/oncotarget.26523
Copyright: © 2019 Apostolidis et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Figure 2. Progression-free survival of first-line therapy.
